(secondQuint)Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection.

 Combination therapy with pegylated interferon-alpha plus ribavirin has greatly improved the treatment efficacy and is the mainstream of treatment for chronic hepatitis C infection.

 Current guideline suggests pegylated interferon monotherapy for patients with acute HCV infection.

 The efficacy might greatly improves if the treatment starts earlier.

 An estimation of 20 percents of patients could recover from acute infection spontaneously within 6 months after exposure,however.

 The present study aims to clarify the efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C six months after onset of acute infection.

 Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection@highlight

Patients with acute hepatitis C virus (HCV) infection usually become chronicity if viremia persists after 6 months of infection.

 The result of using pegylated interferon plus ribavirin combination therapy upon these patients remains to be explored